Home > Newsletters > Devices & Diagnostics Letter > OSC Surveillance Guidance Proves FDA Wrongdoing: Lawyers for Whistleblowers
Devices & Diagnostics Letter
June 25, 2012 | Vol. 39 No. 26
OSC Surveillance Guidance Proves FDA Wrongdoing: Lawyers for Whistleblowers
A new memorandum issued by the U.S. Office of Special Counsel (OSC) instructing federal agencies to ensure their electronic surveillance policies and practices do not deter whistleblowing “confirms” the FDA broke the law when it allegedly monitored the personal emails of employees who voiced product safety concerns to Congress, lawyers for six aggrieved agency staffers say.
ePublishing :: CMS, Hosting & Web Development | © Copyright by FDAnewsAll rights reserved. Do not duplicate or redistribute in any form.